25 67

Cited 0 times in

Usefulness of Self-Expandable Stent for Recanalization of Intracranial Atherosclerotic Disease: Preliminary Experience with Enterprise Stent

DC Field Value Language
dc.contributor.author서상현-
dc.contributor.author이경열-
dc.date.accessioned2022-05-09T16:56:39Z-
dc.date.available2022-05-09T16:56:39Z-
dc.date.issued2022-03-
dc.identifier.issn2093-9043-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188293-
dc.description.abstractPurpose: The purpose of this preliminary study is to evaluate the efficacy and safety of the Enterprise stent for intracranial atherosclerotic disease (ICAD) in patients who presented with acute stroke due to vessel steno-occlusion and in patients with symptomatic disease despite optimum medical management. Materials and methods: A retrospective data analysis was performed on 15 consecutive patients who were treated with Enterprise stenting for recanalization of symptomatic intracranial steno-occlusive arteries due to underlying ICAD. Their clinical and radiological data were reviewed to evaluate procedural results, periprocedural and postprocedural complications, and clinical outcome. Results: Enterprise stents were deployed as a rescue method in 15 patients for recanalization of steno-occlusion. All patients achieved final modified thrombolysis in cerebral infarction (mTICI) score improvement (53.3% with a mTICI score from 0 to 2b or 3, 46.7% with a mTICI score from 1 to 3). Two postprocedural complications (1 symptomatic intracranial hemorrhage and 1 severe brain edema, 13.3%) occurred among 15 patients. Among 12 patients with acute ischemic stroke (AIS), 6 patients (50%) had improvement in their National Institute of Health Stroke Scale of more than 4 at discharge. Seven patients (58.3%) had a good functional outcome with 3-month modified Rankin Score (mRS)≤2, and mortality occurred (mRS=6) in 2 patients (16.7%). None of the 10 AIS and 3 transient ischemic attack patients experienced further ischemic events attributable to the treated steno-occlusion during the follow-up period (ranged from 4 to 36 months, median 12 months). Conclusion: This retrospective study suggests that Enterprise stenting can effectively and safely achieve recanalization in symptomatic steno-occlusive intracranial arteries.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Society of Interventional Neuroradiology-
dc.relation.isPartOfNeurointervention-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleUsefulness of Self-Expandable Stent for Recanalization of Intracranial Atherosclerotic Disease: Preliminary Experience with Enterprise Stent-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiology (영상의학교실)-
dc.contributor.googleauthorWoo Sang Jung-
dc.contributor.googleauthorSam-Soo Kim-
dc.contributor.googleauthorKyung-Yul Lee-
dc.contributor.googleauthorSang Hyun Suh-
dc.identifier.doi10.5469/neuroint.2022.00017-
dc.contributor.localIdA01886-
dc.contributor.localIdA02648-
dc.relation.journalcodeJ02334-
dc.identifier.eissn2233-6273-
dc.identifier.pmid35184435-
dc.subject.keywordIntracranial atherosclerosis-
dc.subject.keywordIntracranial stenting-
dc.subject.keywordIschemic stroke-
dc.contributor.alternativeNameSuh, Sang Hyun-
dc.contributor.affiliatedAuthor서상현-
dc.contributor.affiliatedAuthor이경열-
dc.citation.volume17-
dc.citation.number1-
dc.citation.startPage37-
dc.citation.endPage44-
dc.identifier.bibliographicCitationNeurointervention, Vol.17(1) : 37-44, 2022-03-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.